| Organising Committee |
| Member |
Contact details |
Affiliation |
| Lise Lundh (Chairperson) |
lise.lundh at ge.com |
GE Healthcare Bio-Sciences, Sweden |
| Joseph Bertolini |
joseph.bertolini at csl.com.au |
CSL Limited, Australia |
| Neil Goss |
neil.goss at furtheroptions.com.au |
Further Options Ltd, Australia |
| Jan Berglof |
jan.berglof at abd.com.hk |
JHB Consulting, Sweden |
|
Keynote Speakers |
|
The program of PPB07
started on Tuesday evening of May 8, 2007 with a
keynote address by Dr. Paolo Marcucci, President and CEO of Kedrion, Italy entitled
"Plasma Protein Products and Biotechnology: Facts and Ideas for New Issues and Developments"
A special Focus Lecture was given by Dr. Andrew Chang at
PharmaNet, USA,
who will gave a talk entitled
"FDA’s Pharmaceutical Quality Initiatives: Opportunities and Challenges in the Plasma Fractionation Industry"
|
Chair Persons |
The program was centered around
the following sessions with responsible chairperson as indicated.
| Main Topic |
Chairperson |
Affiliation |
| Manufacturing |
Johan Vandersande/Po-Shing Wah |
Baxter Bioscience, USA |
| New Approaches to Quality |
Tim Hayes |
ProMetic BioTherapeutics Inc., USA |
| Pathogen and Prion Safety |
Hannelore Willkommen |
NewLab BioQuality AG, Germany |
| Clinical Studies |
Darryl Maher |
CSL Limited, Australia |
| Recombinant Plasma Proteins |
Joseph Bertolini |
CSL Limited, Australia |
| Innovations in Plasma |
Claudia Nardini |
Kedrion SpA, Italy |
|
|
|
|
